Israel-Related Stocks Under Pressure After Hamas’ Shock Attack

Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion

Sweden’s Wallenberg Says Business Must Adapt to New World Order

Corporate America Is Ignoring Jay Powell and Bingeing on Debt

Sanofi to Explore Acquisition of Cancer Drugmaker Mirati

Top Vaccine Maker Seeks Growth by Selling Shots to Globetrotters

Ozempic Is Causing ‘Slight Pullback’ by Shoppers, Walmart Says

Palantir Closes In on Controversial UK Health Data Contract

Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker

Thailand Vows Safety for Tourists After Mall Shooting Kills Two

France Bird Flu Vaccine Plan Risks Spooking Foie Gras Lovers

Boohoo’s Plunge Shows Widening Online Gap With Brick-and-Mortar